Evidence and Practice
Effect of dilution and delivery speed on phlebitis after epirubicin chemotherapy
Is online chat a solution or barrier to communicating with people with prostate cancer?
Psychological effects of choosing active surveillance on men with prostate cancer
Clinical
Effect of dilution and delivery speed on phlebitis after epirubicin chemotherapy
Ensuring the right concentration of saline could reduce risk of pain during administration
Is online chat a solution or barrier to communicating with people with prostate cancer?
Methods of communication have become less personal and more reliant on technology
Psychological effects of choosing active surveillance on men with prostate cancer
The psychological effects of active surveillance and how nurses can support patients
How people with myeloma perceive patient-reported outcome measures
Views of patients and family members about commonly used patient-reported outcome measures
Sexual activity after treatment for head and neck cancer: the experience of survivors
It is critical that healthcare providers meet the informational needs of this population
Coming out in cancer care: is disclosure of sexual orientation beneficial?
Nurses and other health professionals are expected to ask patients about sexual orientation
CPD articles
Enhancing well-being and building resilience in people living with cancer part 2: a...
Receiving a new diagnosis of cancer or of its recurrence is distressing and there are...
Developing best practice cancer treatment summary templates
There is increasing recognition of the importance of making the Recovery Package available...
Oral vinorelbine: a practical approach to patient management
Oral vinorelbine has been a well-established cytotoxic treatment for non-small cell lung...
Advance care planning: considerations for clinical practice
Advance care planning (ACP) is a process of establishing a person’s preferences and wishes,...
Practical experience with rituximab subcutaneous
Treatment regimens involving the monoclonal anti-CD20 antibody rituximab are the standard of...
Use of olaparib in BRCA mutation-positive ovarian cancer
Nurses should understand the role and purpose of the new generation of therapies available...